Little is known about the regulatory mechanisms of antifungal host defense. Two complementary studies show that the E3 ubiquitin ligase CBLB targets dectin-1 and dectin-2 for degradation, and thus exerts a strong anti-inflammatory effect.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Marina Corral Spence/Nature Publishing Group
References
Brown, G.D. et al. Sci. Transl. Med. 4, 165rv13 (2012).
Netea, M.G., Joosten, L.A., van der Meer, J.W., Kullberg, B.J. & van de Veerdonk, F.L. Nat. Rev. Immunol. 15, 630–642 (2015).
Rogers, N.C. et al. Immunity 22, 507–517 (2005).
Gross, O. et al. Nature 442, 651–656 (2006).
Xiao, Y. et al. Nat. Med. 22, 906–914 (2016).
Wirnsberger, G. et al. Nat. Med. 22, 915–923 (2016).
Gazendam, R.P. et al. Blood 124, 590–597 (2014).
Bachmaier, K. et al. Nature 403, 211–216 (2000).
Gross, O. et al. Nature 459, 433–436 (2009).
Cheng, S.C. et al. J. Leukoc. Biol. 90, 357–366 (2011).
Vonk, A.G. et al. J. Infect. Dis. 193, 1419–1426 (2006).
Quintin, J. et al. Cell Host Microbe 12, 223–232 (2012).
Acknowledgements
M.G.N. was supported by an ERC Consolidator Grant (#310372) and a Spinoza Grant of the Netherlands Organization for Scientific Research (NWO). F.L.V. was supported by the ERA-Net for Research Programs on Rare Diseases, 'EURO-CMC'.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
van de Veerdonk, F., Netea, M. CBLB ubiquitin ligase: a major regulator of antifungal immunity. Nat Med 22, 834–835 (2016). https://doi.org/10.1038/nm.4160
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm.4160
